Browsing Tag
kidney disease
14 posts
Novartis wins FDA approval for Fabhalta, the first treatment for C3 glomerulopathy
Novartis secures FDA approval for Fabhalta, the first-ever treatment for C3G. Find out how this breakthrough impacts patients and investors.
March 21, 2025
Humana expands value-based care with new cancer and kidney disease initiatives
Humana Inc., a leading health and well-being company, has reinforced its commitment to value-based care by introducing two…
February 26, 2025
Hypertension: Understanding the causes, symptoms, and effective management
Hypertension, commonly known as high blood pressure, is a chronic condition where the force of blood against the…
February 23, 2025
FDA grants Otsuka’s Sibeprenlimab breakthrough therapy designation in IgAN
In a significant development for the treatment of kidney disease, the U.S. Food and Drug Administration (FDA) has…
February 17, 2024
Novartis acquires kidney disease innovator Chinook Therapeutics
Swiss pharmaceutical giant Novartis has wrapped up the previously announced $3.5 billion acquisition of Seattle-based biopharmaceutical firm Chinook…
August 14, 2023
FDA approves Gilead’s Veklury for COVID-19 patients with severe renal impairment
Gilead Sciences said that the US Food and Drug Administration (FDA) has approved a supplemental new drug application…
July 14, 2023
ProKidney to acquire manufacturing facility in North Carolina for REACT commercial production
ProKidney, a late clinical-stage cellular therapeutics company, has announced plans to acquire a 210,000 square foot facility and…
June 13, 2023
Novartis to expand renal portfolio with Chinook Therapeutics acquisition
Novartis has announced its agreement to acquire Chinook Therapeutics, a clinical stage biopharmaceutical company based in Seattle, Washington…
June 12, 2023
AstraZeneca wraps up $1.8bn acquisition of CinCor Pharma
AstraZeneca has closed the previously announced $1.8 billion acquisition of US biopharmaceutical company CinCor Pharma. Under the terms…
February 28, 2023
GSK gets Jesduvroq FDA approval for anaemia of chronic kidney disease
GSK has secured the approval of the US Food and Drug Administration (FDA) for the company’s Jesduvroq (daprodustat)…
February 4, 2023